IP Verse

Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist - EP3506931

The patent EP3506931 was granted to Regeneron Pharmaceuticals on Jul 31, 2024. The application was originally filed on Aug 31, 2017 under application number EP17771619A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3506931

REGENERON PHARMACEUTICALS
Application Number
EP17771619A
Filing Date
Aug 31, 2017
Status
Granted And Under Opposition
Jun 27, 2024
Grant Date
Jul 31, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTApr 30, 2025BOULT WADE TENNANTADMISSIBLE
HAMPTON KNOWLESApr 30, 2025D YOUNGADMISSIBLE
SECERNAApr 30, 2025SECERNAADMISSIBLE
LUIGIApr 29, 2025TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (26) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2011027468
DESCRIPTIONUS2014072583
DESCRIPTIONUS6927044
DESCRIPTIONUS7186809
DESCRIPTIONUS7531637
DESCRIPTIONUS7582298
DESCRIPTIONUS7605237
DESCRIPTIONUS7608693
DESCRIPTIONUS7638606
DESCRIPTIONUS8092804
DESCRIPTIONUS8679487
DESCRIPTIONUS8877189
DESCRIPTIONUS8945559
INTERNATIONAL-SEARCH-REPORTUS2014356372
INTERNATIONAL-SEARCH-REPORTUS2015185228
INTERNATIONAL-SEARCH-REPORTUS2016152718
INTERNATIONAL-SEARCH-REPORTWO2014031610
INTERNATIONAL-SEARCH-REPORTWO2014039461
INTERNATIONAL-SEARCH-REPORTWO2014205365
INTERNATIONAL-SEARCH-REPORTWO2016077675
INTERNATIONAL-SEARCH-REPORTWO2017143270
OPPOSITIONWO2014031610
OPPOSITIONWO2015127229
OPPOSITIONWO2016077675
OPPOSITIONWO2018045130
OPPOSITIONWO2022076289

Non-Patent Literature (NPL) Citations (51) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- CORREN et al., Am J Respir Crit Care Med., (20100000), vol. 181, no. 8, pages 788 - 796
DESCRIPTION- GOODSON, Medical Applications of Controlled Release, (19840000), vol. 2, pages 115 - 138
DESCRIPTION- KLEIN et al., mAbs, (20120000), vol. 4, no. 6, pages 1 - 11
DESCRIPTION- LANGER, Science, (19900000), vol. 249, pages 1527 - 1533
DESCRIPTION- MERRETT et al., Allergy, (19870000), vol. 17, pages 409 - 416
DESCRIPTION- MORDENTI et al., Pharmaceut. Res., (19910000), vol. 8, page 1351
DESCRIPTION- POWELL et al., "Compendium of excipients for parenteral formulations", J Pharm Sci Technol, (19980000), vol. 52, pages 238 - 311, XP009119027
DESCRIPTION- Remington's Pharmaceutical Sciences, Mack Publishing Company
DESCRIPTION- SEFTON, CRC Crit. Ref. Biomed. Eng., (19870000), vol. 14, page 201
DESCRIPTION- TAYLOR et al., Nucl. Acids Res., (19920000), vol. 20, pages 6287 - 6295
DESCRIPTION- WU et al., J. Biol. Chem., (19870000), vol. 262, pages 4429 - 4432
INTERNATIONAL-SEARCH-REPORT- BECK LISA A ET AL, "Dupilumab treatment in adults with moderate-to-severe atopic dermatitis", NEW ENGLAND JOURNAL OF MEDICINE, THE -, MASSACHUSETTS MEDICAL SOCIETY, US, (20140710), vol. 371, no. 2, doi:10.1056/NEJMOA1314768, ISSN 1533-4406, pages 130 - 139, XP009180485 [A] 1-37 * abstract * * page 132, paragraph Combination Therapy for 4 Weeks * * page 134, paragraph Combination Therapy at 4 Weeks *
INTERNATIONAL-SEARCH-REPORT- JENNIFER D HAMILTON ET AL, "Drug evaluation review: dupilumab in atopic dermatitis", IMMUNOTHERAPY, GB, (20151001), vol. 7, no. 10, doi:10.2217/imt.15.69, ISSN 1750-743X, pages 1043 - 1058, XP055421912 [A] 1-37 * page 1049, column l, paragraph 2; figures 3,4; table 6 *
OPPOSITION- Anonymous, "3- Allergens and trigger factors ", The journal of allergy and clinical immunoolgy, (20011101), vol. 108, no. 5, pages S162 - S170, XP093276389
OPPOSITION- Anonymous, "6 - Co-morbidity and complications", The journal of allergy and clinical immunoolgy, (20011101), vol. 108, no. 5, pages S198 - S207, XP093276395
OPPOSITION- Anonymous, "Annex I Summary of product characteristics - dupilumab ", EMA, (20220902), pages 1 - 7, XP093276493
OPPOSITION- Anonymous, "Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)", Clinical Trials - NCT02414854, (20181023), pages 1 - 44, XP093276401
OPPOSITION- Anonymous, "Immunotherapy proves to be e!ective for the treatment of chronic rhinosinusitis with nasal polyps", Clinic Barcelona, (20160202), pages 1 - 4, Clinic Barcelona, URL: https://www.clinicbarcelona.org/en/news/immunotherapy-proves-to-be-effective-for-the-treatment-of-chronic-rhinosinusitis-with-nasal-polyps, XP093276341
OPPOSITION- Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN) ", WHO Drug Information, (20120101), vol. 26, no. 4, pages 401 - 402 + 412, XP055928716
OPPOSITION- Anonymous, "Passage ; Biopharmaceutics and Clinical Pharmacokinetics", Anonymous, Gibaldi Milo, Biopharmaceutics and Clinical Pharmacokinetics, fourth edition, Lea& Febiger , (19910101), pages 12 - 13, ISBN 978-0-8121-1346-4, XP093276442
OPPOSITION- Anonymous, "Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients", Regeneron, (20160401), pages 1 - 4, Regeneron, URL: https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-dupilumab-topline-results, XP093276485
OPPOSITION- Anonymous, "Something new under the skin", Nature biotechnology, (20110201), vol. 29, no. 2, pages 107 - 109, XP093276437
OPPOSITION- Bai Shuang, Jorga Karin, Xin Yan, Jin Denise, Zheng Yanan, Damico-Beyer Lisa A, Gupta Manish, Tang Meina, Allison David E, Lu Dan, Zhang Yi, Joshi Amita, Dresser Mark J, "A Guide to Rational Dosing of Monoclonal Antibodies", Clinical Pharmacokinetics, (20120101), vol. 51, no. 2, pages 119 - 135, XP093238095
OPPOSITION- Chervinsky, P. ; Casale, T. ; Townley, R. ; Tripathy, I. ; Hedgecock, S. ; Fowler-Taylor, A. ; Shen, H. ; Fox, H., "Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis", Annals of Allergy, Asthma, AMSTERDAM, NL, (20030801), vol. 91, no. 2, ISSN 1081-1206, pages 160 - 167, XP026958867
OPPOSITION- Sheldon J, Miller L , "Allergy Diagnosis Reference Guide - Revision: 4 ", NHS, (20141001), pages 1 - 10, NHS, URL: https://www.mtw.nhs.uk/wp-content/uploads/2015/08/Allergy_diagnosis_reference_guide.pdf, XP093276449
OPPOSITION- Vidal C, Gude F, Boquete O, Fernández-Merino M C, Meijide L M, Rey J, Lojo S, González-Quintela A, "Evaluation of the Phadiatop™ test in the diagnosis of allergic sensitization in a general adult population", JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, ES , (20050101), vol. 15, no. 2, ISSN 1018-9068, pages 124 - 130, XP093276377
OPPOSITION- Vignola A M, Humbert M, Bousquet J, Boulet L-P, Hedgecock S, Blogg M, Fox H, Surrey K, "Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR", Allergy, (20040101), vol. 59, pages 709 - 717, XP093276418
OPPOSITION- Claus Bachert, Mannent Leda, Naclerio Robert M., Mullol Joaquim, Ferguson Berrylin J., Gevaert Philippe, Hellings Peter, Jiao Lixia, Wang Lin, Evans Robert R., Pirozzi Gianluca, Graham Neil M., Swanson Brian, Hamilton Jennifer D., Radin Allen, Gandhi Namita A., Stahl Neil, Yancopoulos George D., Sutherland E. Rand, "Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis : A Randomized Clinical Trial", JAMA, Chicago, IL, (20160202), vol. 315, no. 5, doi:10.1001/jama.2015.19330, ISSN 0098-7484, pages 469 - 479, XP055418337
OPPOSITION- Sheikh Aziz, Hurwitz Brian, Nurmatov Ulugbek, Van Schayck Constant Paul, "House dust mite avoidance measures for perennial allergic rhinitis", Cochrane Database of Systematic Reviews, US , (20100101), doi:10.1002/14651858.CD001563.pub3, ISSN 1465-1858, pages 1 - 24, XP093276432
OPPOSITION- Pepper Amber N, Dennis K. Ledford , "Allergic Rhinitis: Diagnosis and Treatment", Pepper Amber N, Dennis K. Ledford , Massoud Mahmoudi, Allergy and Asthma - Practical Diagnosis and Management Second Edition, Springer, Cham, (20160101), pages 63 - 85, doi:10.1007/978-3-319-30835-7_6, ISBN 978-3-319-30833-3, XP093276366
OPPOSITION- Pomés Anna; Chapman Martin D; Wünschmann Sabina, "Indoor Allergens and Allergic Respiratory Disease", Current Allergy and Asthma Reports, New York, (20160516), vol. 16, no. 6, doi:10.1007/s11882-016-0622-9, ISSN 1529-7322, pages 1 - 10, XP035686798
OPPOSITION- Salo Päivi M., Calatroni Agustin, Gergen Peter J., Hoppin Jane A., Sever Michelle L., Jaramillo Renee, Arbes Samuel J., Zeldin Darryl C., "Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey 2005-2006", Author manuscript - Journal of Allergy and Clinical Immunology, AMSTERDAM, NL , (20110501), vol. 127, no. 5, doi:10.1016/j.jaci.2010.12.1106, ISSN 0091-6749, pages 1 - 19, XP093276342
OPPOSITION- Dixon Anne E., Castro Mario, Cohen Rubin I., Gerald Lynn B., Holbrook Janet T., Irvin Charles G., Mohapatra Shyam, Peters Stephen P., Rayapudi Sobharani, Sugar Elizabeth A., Wise Robert A., "Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma", Journal of Allergy and Clinical Immunology, AMSTERDAM, NL , (20150301), vol. 135, no. 3, doi:10.1016/j.jaci.2014.06.038, ISSN 0091-6749, pages 701 - 709.e5, XP093276427
OPPOSITION- Muraro Antonella; Lemanske Robert F.; Hellings Peter W.; Akdis Cezmi A.; Bieber Thomas; Casale Thomas B.; Jutel Marek; Ong Peck Y.; Poulsen Lars K.; Schmid-Grendelmeier Peter; Simon Hans-Uwe; Seys Sven F.; Agache Ioana, "Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology", Journal of Allergy and Clinical Immunology, AMSTERDAM, NL , (20160504), vol. 137, no. 5, doi:10.1016/j.jaci.2016.03.010, ISSN 0091-6749, pages 1347 - 1358, XP029531188
OPPOSITION- Wenzel Sally, Castro Mario, Corren Jonathan, Maspero Jorge, Wang Lin, Zhang Bingzhi, Pirozzi Gianluca, Sutherland E Rand, Evans Robert R, Joish Vijay N, Eckert Laurent, Graham Neil M H, Stahl Neil, Yancopoulos George D, Louis-Tisserand Mariana, Teper Ariel, "Supplementary appendix: Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial", The Lancet, AMSTERDAM, NL , (20160701), vol. 388, no. 10039, doi:10.1016/S0140-6736(16)30307-5, pages 31 - 27, XP093201226
OPPOSITION- Wenzel Sally, Ford Linda, Pearlman David, Spector Sheldon, Sher Lawrence, Skobieranda Franck, Wang Lin, Kirkesseli Stephane, Rocklin Ross, Bock Brian, Hamilton Jennifer, Ming Jeffrey E., Radin Allen, Stahl Neil, Yancopoulos George D., Graham Neil, Pirozzi Gianluca, "Supplement to: Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels.", The New England journal of medicine, US , (20130627), vol. 368, no. 26, doi:10.1056/NEJMoa1304048, ISSN 0028-4793, pages 2455 - 2466, XP093197887
OPPOSITION- Skoner David P., "Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis", Journal of Allergy and Clinical Immunology, AMSTERDAM, NL , (20010701), vol. 108, no. 1, doi:10.1067/mai.2001.115569, ISSN 0091-6749, pages S2 - S8, XP093276354
OPPOSITION- Bousquet J, "Allergic rhinitis and its impact on asthma - Recommendations ", Journal of Allergy and Clinical Immunology, (20011101), vol. 108, no. 5, doi:10.1067/mai.2001.118891, pages S147 - S152, XP093276506
OPPOSITION- J. Bousquet; N. Khaltaev; A. A. Cruz; J. Denburg; W. J. Fokkens; A. Togias; T. Zuberbier; C. E. Baena‐Cagnani; G. W. Canonica; C. Van Weel; I. Agache; N. Aït‐Khaled; C. Bachert; M. S. Blaiss; S. Bonini; L.‐P. Boulet; P.‐J. Bousquet; P. Camargos; K.‐H. Carlsen; Y. Chen; A. Custovic; R. Dahl; P. Demoly; H. Douagui; S. R. Durham; R. Gerth Van Wijk; O. Kalayci; M. A. Kaliner; Y.‐Y. Kim; M. L. Kowalski; P. Kuna; L. T. T. Le; C. Lemiere; J. Li; R. F. Lockey; S. Mavale‐Manuel; E. O. Meltzer; Y. Mohammad; J. Mullol; R. Naclerio; R. E. O’Hehir; K. Ohta; S. Ouedraogo; S. Palkonen; N. Papadopoulos; G. Passalacqua; R. Pawankar; T. A. Popov; K. F. Rabe; J. Rosado‐Pinto; G. K. Scadding; F. E. R. Simons; E. Toskala; E. Valovirta; P. Van Cauwenberge; D.‐Y. Wang; M. Wickman; B. P. Yawn; A. Yorgancioglu; O. M. Yusuf; H. Zar; I. Annesi‐Maesano; E. D. Bateman; A. Ben Kheder; D. A. Boakye; J. Bouchard; P. Burney; W. W. Busse; M. Chan‐Yeung; N. H. Chavannes; A. Chuchalin; W. K. Dole, "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*", Allergy, United Kingdom , (20080307), vol. 63, doi:10.1111/j.1398-9995.2007.01620.x, ISSN 0105-4538, pages 8 - 160, XP071460842
OPPOSITION- C. Hopkins; S. Gillett; R. Slack; V.J. Lund; J.P. Browne, "Psychometric validity of the 22‐item Sinonasal Outcome Test", Clinical Otolaryngology, Hoboken, USA, (20090924), vol. 34, no. 5, doi:10.1111/j.1749-4486.2009.01995.x, ISSN 1749-4478, pages 447 - 454, XP072387427
OPPOSITION- Juniper E F, Guyatt G H, Epstein R S, Ferrie P J, Jaeschke R, Hiller T K, "Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.", Thorax, GB , (19920201), vol. 47, no. 2, doi:10.1136/thx.47.2.76, ISSN 0040-6376, pages 76 - 83, XP093276425
OPPOSITION- Borish Larry, "IL-4 and IL-13 Dual Antagonism : A Promising Approach to the Dilemma of Generating Effective Asthma Biotherapeutics", American Journal of Respiratory and Critical Care Medicine, (20100415), vol. 181, no. 8, doi:10.1164/rccm.201002-0147ED, ISSN 1073-449X, pages 769 - 770, XP055944399
OPPOSITION- Steinke John W; Borish Larry, "Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists", Respiratory research, GB , (20010219), vol. 2, no. 2, doi:10.1186/rr40, ISSN 1465-9921, pages 66 - 70, XP021021406
OPPOSITION- Egan Maureen, Bunyavanich Supinda, "Allergic rhinitis: the “Ghost Diagnosis” in patients with asthma", Asthma Research and Practice, London, UK , (20151201), vol. 1, no. 1, doi:10.1186/s40733-015-0008-0, ISSN 2054-7064, pages 1 - 7, XP093276410
OPPOSITION- A. T. Nials, S. Uddin, "Mouse models of allergic asthma: acute and chronic allergen challenge", Disease Models & Mechanisms, GB , (20081101), vol. 1, no. 4-5, doi:10.1242/dmm.000323, ISSN 1754-8403, pages 213 - 220, XP055537092
OPPOSITION- Sin B., Togias A., "Pathophysiology of Allergic and Nonallergic Rhinitis", AMERICAN THORACIC SOCIETY, US , (20110101), vol. 8, no. 1, doi:10.1513/pats.201008-057RN, ISSN 1546-3222, pages 106 - 114, XP093276446
OPPOSITION- Johansson S G O, "ImmunoCAP Specific IgE test: an objective tool for research and routine allergy diagnosis.", Expert Reviews in Molecular Diagnostics, GB , (20040501), vol. 4, no. 3, doi:10.1586/14737159.4.3.273, ISSN 1473-7159, pages 273 - 279, XP008136793
OPPOSITION- Boulet Louis-Philippe, Boulay Marie-Ève, "Asthma-related comorbidities", Expert Review of Respiratory Medicine, GB , (20110601), vol. 5, no. 3, doi:10.1586/ers.11.34, ISSN 1747-6348, pages 377 - 393, XP093276462
OPPOSITION- Vatrella Alessandro, Fabozzi Immacolata, Calabrese Cecilia, Maselli Rosario, Pelaia Girolamo, "Dupilumab: a novel treatment for asthma", Journal of Asthma and Allergy, (20140101), doi:10.2147/JAA.S52387, ISSN 1178-6965, pages 123 - 130, XP093276479
OPPOSITION- Nayak Anjuli, Langdon Ronald B, "Montelukast in the Treatment of Allergic Rhinitis: An Evidence-Based Review", Drugs, Auckland, (20070101), vol. 67, no. 6, doi:10.2165/00003495-200767060-00005, ISSN 0012-6667, pages 887 - 901, XP093276349
OPPOSITION- Corsico Angelo G., De Amici Mara, Ronzoni Vanessa, Giunta Vania, Mennitti Maria Chiara, Viscardi Arianna, Marseglia Gian Luigi, Ciprandi Giorgio, "Allergen-Specific Immunoglobulin E and Allergic Rhinitis Severity", Allergy & Rhinology, (20170101), vol. 8, no. 1, doi:10.2500/ar.2017.8.0187, ISSN 2152-6575, pages e1 - e4, XP093276379

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents